Status:
UNKNOWN
Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously
Lead Sponsor:
Yanqing Li
Conditions:
Head and Neck Cancer
Esophageal Cancer Stage
Eligibility:
All Genders
Brief Summary
To summarise the outcomes of a treatment decision of patients with superficial esophageal carcinoma synchronously associated with head and neck cancer, that is endoscopic treatment for the superficial...
Detailed Description
As a same risk factor, such as heavy drinking and smoking, patients with head and ncek carcinoma are always suffering from synchronous esophageal squamous cell carcinoma. Previous studies illustrated ...
Eligibility Criteria
Inclusion
- Patients with head and ncek carcinoma associated with synchronous superficial esophageal squamous cell carcinoma.
- Patients agree to be treated with esophageal endoscopic submucosal dissection firstly, then accept surgery of head and neck carcinoma.
Exclusion
- Patients refuse a endoscopic submucosal dissection or surgery.
- Patients with sever systemic disease, such as sever cardiopulmonary disease, renal failure and impaired blood coagulation.
- Obstruction of the pharynx leading to a failure of insertion of endoscopy.
- Patients with an advanced esophageal carcinoma evaluated by endoscopy.
Key Trial Info
Start Date :
March 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 7 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03450447
Start Date
March 10 2018
End Date
May 7 2020
Last Update
March 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012